Related Experiment Video
Updated: Apr 4, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Review of New Statistical Techniques for Analysis of Cardiovascular Trial and Registry Data
Dhammika Amaratunga1, Javier Cabrera
1Rutgers Cardiovascular Institute, Rutgers University, Newark, NJ, USA.
Abstract:
Cardiovascular research generates a large variety of data including big and small datasets that pose interesting challenges to researchers in biomedical statistics. This paper covers a number of important methodology issues and the solutions that have been applied so far to try to solve them. The first issue is multiple testing and the use of false discovery rates to correct for multiplicity. This is illustrated with an application related to genotyping heart diseases. The second is measuring life extension at present and in the future. The third one is the issue of U and J curves and the questions they present. Finally, this paper studies visit-to-visit blood pressure variability as a predictor of cardiovascular events.
More Related Videos
Related Concept Videos
Statistical Methods for Analyzing Epidemiological Data
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Comparing the Survival Analysis of Two or More Groups
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Statistical Software for Data Analysis and Clinical Trials

